Notices. Notice

7,984 words·~36 min read·/register/2006/06/05/06-5080·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: GLP-1 Exendin-4 Peptide Analogs and Uses Thereof AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license worldwide to practice the invention embodied in U.S.

Patent Application Number 10/485,140 filed January 27, 2004, entitled “GLP-1 Exendrin-4 Peptide Analogs and Uses Thereof,” to Amylin Pharmaceuticals, Inc., having a place of business in San Diego, CA 92121. The contemplated exclusive license may be limited to use to human therapeutics for diabetes, obesity and cardiovascular disease, as well as neurological and neurodegenerative diseases, disorders and injuries. The United States of America is the assignee of the patent rights in this invention.

DATES: Only written comments and/or application for a license which is received by the NIH Office of Technology Transfer on or before August 4, 2006 will be considered. ADDRESSES: Request for a copy of the patent, inquires, comments, and other materials relating to the contemplated license should be directed to: Marlene Astor, Technology Licensing Specialist, Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804;

Telephone: 301-435-4426; Facsimile: 301-402-0220; e-mail: *ms482m@nih.gov* . SUPPLEMENTARY INFORMATION: Type-2 diabetes and neurodegeneration ( *e.g.* , Alzheimer's disease, Parkinson's disease, peripheral neuropathy, stroke) are leading causes of death in the United States and worldwide. The present invention pertains to the disclosure of novel peptide analogues of Glucagons-like peptide-1 (GLP-1) and Exendin-4 and their uses in the treatment of

(i)diabetes and

(ii)neurodegenerative disorders. Type-2 diabetes is caused by dysfunction of the pancreatic beta cells that may result in concomitant decrease in insulin production. Insulin replacement has been an effective therapy for the treatment of Type-2 diabetes. However, insulin therapy, although life saving, does not restore normal levels of glucose and postprandial levels of glucose continues to be excessively high in individuals on insulin therapy. Further, the therapy may result in adverse effects including hyperglycemia, hypoglycemia, metabolic acidosis and ketosis. Therefore, a better therapeutic formula may be needed that may increase the efficacy of the treatment and minimize the side effects. The present invention discloses a method of treating a subject with diabetes with novel GLP-1/Exendin-4 peptides. These are GLP-1 agonists and elicit insulinotropic actions. The GLP-1 receptor is additionally found in the brain as well as associated to pancreatic islets cells. Its stimulation in brain has been found to be neurotrophic and neuroprotective in both tissue culture and in vivo against a variety of toxic insults. Peptides of the said invention possess activity in a variety of predictive models of neurodegeneration, and may have potential in a variety of diseases both associated (peripheral neuropathy) and unassociated (Alzheimer's disease, Parkinson's disease, stroke and peripheral neuropathy) with diabetes J. Alz. Dis. 4: 487-96, 2002; J. Pharmacol. Exp. Ther. 300:958-66, 2002 & 302:881-888, 2002. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 60 days from the date of this published Notice, the NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: May 26, 2006. David R. Sadowski, Acting Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6-8678 Filed 6-2-06; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Co-Exclusive License: Human Monoclonal Antibody, Their Fragments and Derivatives as Biotherapeutics for the Treatment of HIV Infections AGENCY: National Institutes of Health, Public Health Service, HHS. ACTION: Notice. SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a co-exclusive license to practice the inventions embodied in: 1. U.S. Provisional Patent Application Serial No. S/N 60/378,406, PCT/US03/14905, NIH

(DHHS)Ref. No. E-144-2002/1-PCT-02 converted into 03733940.5 (E-144-2002/1-EP-04) filed in Europe on November 25, 2004, and 2003239356 (E-144-2002/1-AU-05) filed in Australia October 29, 2004, 10/512,966 (E-144-2002/1-US-03) filed in USA October 28, 2004, as well as 2485120 (E-144-2002/1-CA-06) filed in Canada May 6, 2003, entitled: “Identification of Novel Broadly Cross-Reactive Neutralizing Human Monoclonal Antibodies”. Inventor(s): Dimiter S. Dimitrov

(NCI)and Mei-Yun Zhang (SAIC). 2. U.S. Patent Application, S/N 60/506,946 (E-316-2003/0-US-01), PCT/US2004/31878 (E-316-2003/0-PCT-02) entered the national stage filing on March 29, 2006 in USA (E-316-2003/0-US-03), in Canada (E-316-2003/0-CA-04), in Europe (E-316-2003/0-EP-05), and in Australia (E-316-2003/0-AU-06), entitled: “Immunoglobulins With Potent and Broad Antiviral Activity”. Inventor(s): Dimiter S. Dimitrov

(NCI)and Mei-Yun Zhang

(SAIC)to Virosys Pharmaceuticals Inc. (hereafter Virosys) having a place of business in Los Altos Hills, California, and Profectus Biosciences, Inc. (hereafter Profectus) having a place of business in Baltimore, Maryland. The patent rights in these inventions have been assigned to the United States of America. DATES: Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before August 4, 2006 will be considered. ADDRESSES: Requests for a copy of the patent application, inquiries, comments and other materials relating to the contemplated license should be directed to: Sally Hu, Ph.D., M.B.A., Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804; E-mail: *hus@od.nih.gov* ; Telephone:

(301)435-5606; Facsimile:

(301)402-0220. SUPPLEMENTARY INFORMATION: The first invention (E-144-2002/1-PCT-02) describes two single chain fragment variable

(scFv)clones, designated M6 and M9 that were selected from phage-displayed X5 scFv mutants library by panning the library against gp <sup>12089.6/IIIB</sup> -CD4 complex using the alternating antigen panning strategy (AAP). M6 and M9 are stable and have significant improved binding activities to gp <sup>120IIIB</sup> . Both scFvs inhibit more efficiently membrane fusion of HIV mediated by envelop glycoproteins of primary HIV isolates with a broader spectrum compared to other antibodies such as X5, indicating that the scFv form may be a more proper form compared to the Fab form for HIV-1 neutralizing antibodies to inhibit virus infection and transmission. Furthermore, scFv is a single molecule almost half the size of Fab, which makes it more suitable for constructing bivalent and multivalent antibodies and antibody fusion proteins. M6 and M9 are cross-reactive with HIV-1 isolates so that these antibodies could be directly used for therapy of HIV-1 infected individuals. In addition, these antibodies can also be used for screening of peptide phage display libraries, libraries of Envs, and in general as tools for development of HIV vaccines and therapeutics. The second invention (E-316-2003) describes methods of inhibiting viral infection, such as HIV-1, by administering a fusion protein comprising a small size, single chain Fv

(scFv)antibody-binding domain joined to an Fc region by a long flexible linker. In particular, scFv M6 or M9, and their complex with two-domain soluble CD4 are joined to Fc by a long flexible linker to provide a new agent for the inhibition of HIV infection or immunotherapy of HIV-infected individuals. The Fc region provides stability, long half-life, and biological effector functions. The scFv-Fc fragment provides antigen recognition and neutralizing activity. The small size of the scFv-Fc fusion molecule provides easy access to conserved viral epitopes exposed before or during viral entry. In addition, these fusion molecules exhibit neutralization activity that is higher than that of whole IgGs, and comparable to or better than that of scFv. Thus, this invention may offer a novel approach to treat and prevent HIV-1 infection and/or AIDS, is related to invention E-144-2002/1, and may strengthen the company's portfolio of technologies being developed. The prospective co-exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective co-exclusive license may be granted unless, within 60 days from the date of this published Notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The field of use may be limited to the development of human monoclonal antibodies for use as a therapeutic or preventative in HIV infection either alone or in combination with other compounds. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: May 26, 2006. David R. Sadowski, Acting Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6-8680 Filed 6-2-06; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Availability of the Draft NTP Brief on Di-(2-ethylhexyl) phthalate; Request for Public Comments AGENCY: National Institute for Environmental Health Sciences (NIEHS); National Institutes of Health (NIH). ACTION: Request for comments. SUMMARY: CERHR invites the submission of public comments on the draft NTP Brief for di-(2-ethylhexyl)phthalate (DEHP). The draft NTP Brief is available from the CERHR Web site ( *http://cerhr.niehs.nih.gov* see “CERHR Reports & Monographs”) or in hardcopy from CERHR (see ADDRESSES below). Public comments will be considered during the peer review and finalization of the NTP Brief. DATES: Written comments on the draft NTP Brief for DEHP should be received by July 5, 2006. ADDRESSES: Public comments and any other correspondence should be addressed to Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box 12233, MD EC-32, Research Triangle Park, NC 27709 (mail),

(919)541-3455 (phone),

(919)316-4511 (fax), or *shelby@niehs.nih.gov* (e-mail). Courier address: CERHR, 79 T.W. Alexander Drive, Building 4401, Room 103, Research Triangle Park, NC 27709. SUPPLEMENTARY INFORMATION: Background DEHP (CAS RN: 117-81-7) is a high production volume chemical used as a plasticizer of polyvinyl chloride in the manufacturer of a wide variety of consumer products, such as building products, car products, clothing, food packaging, children's products (but not in toys intended for mouthing) and in polyvinyl chloride medical devices. On October 10-12, 2005, CERHR convened an expert panel to conduct an updated evaluation of the potential reproductive and developmental toxicities of DEHP. The expert panel report was released for public comment on November 21, 2005 ( **Federal Register** Vol. 70, No. 220, pp. 69567, November 16, 2005). Following this public comment period, CERHR staff prepared the draft NTP Brief for DEHP that provides in plain language: • Background information on the substance(s). • Findings of the expert panel. • Discussion of any relevant data available after the expert panel meeting. • NTP's conclusions on the potential for the substance to cause adverse reproductive and/or developmental effects in exposed humans. Upon finalization, the NTP Brief for DEHP will be included in the CERHR Monograph for DEHP. The draft NTP Brief for DEHP and related background materials, including the DEHP expert panel report and previously received public comments, are available on the CERHR Web site ( *http://cerhr.niehs.nih.gov* see Di-(2-ethylhexyl)phthalate under “CERHR Reports & Monographs”). Request for Comments The NTP invites written public comments on the draft NTP Brief for DEHP. Any comments received will be posted on the CERHR Web site and considered during the peer review and finalization of the NTP Brief for DEHP. Persons submitting written comments are asked to include their name and contact information (affiliation, mailing address, telephone and facsimile numbers, e-mail, and sponsoring organization, if any) and submit comments to Dr. Shelby (see ADDRESSES above) for receipt by July 5, 2006. Background Information on CERHR The NTP established CERHR in June 1998 [ **Federal Register** , December 14, 1998 (Volume 63, Number 239, page 68782)]. CERHR is a publicly accessible resource for information about adverse reproductive and/or developmental health effects associated with exposure to environmental and/or occupational exposures. CERHR invites the nomination of agents for review or scientists for its expert registry. Information about CERHR and the nomination process can be obtained from its homepage ( *http://cerhr.niehs.nih.gov* ) or by contacting Dr. Michael Shelby, CERHR Director (see ADDRESSES ). CERHR selects chemicals for evaluation based upon several factors including production volume, potential for human exposure from use and occurrence in the environment, extent of public concern, and extent of data from reproductive and developmental toxicity studies. Expert panels conduct scientific evaluations of agents selected by CERHR in public forums. Following these evaluations, CERHR prepares the NTP-CERHR monograph on the agent evaluated. The monograph is transmitted to appropriate federal and state agencies and made available to the public. Dated: May 25, 2006. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E6-8677 Filed 6-2-06; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG-2006-24935] Merchant Marine Personnel Advisory Committee; Notice of Open Teleconference Meetings AGENCY: Coast Guard, DHS. ACTION: Notice of meetings. SUMMARY: This notice announces teleconferences of the Merchant Marine Personnel Advisory Committee (MERPAC). The Federal Advisory Committee Act (Pub. L. 92-463, 86 Stat. 770) requires that public notice of these meetings be announced in the **Federal Register** . The purpose of these teleconferences is for MERPAC to discuss and prepare comments to the docket on the joint Transportation Security Administration's

(TSA)and Coast Guard's Transportation Worker's Identification Credential

(TWIC)proposed rule and on the Coast Guard's Merchant Mariner Credential

(MMC)proposed rule. MERPAC provides advice and makes recommendations to the Coast Guard on matters related to the training, qualification, licensing, certification, and fitness of seamen serving in the U.S. merchant marine. DATES: The teleconference calls will take place on Tuesday, June 20th, 2006, from 12 p.m. until 3 p.m., and on Thursday, June 29th, 2006, from 12 p.m. until 3 p.m. These meetings may adjourn early if all business is finished. ADDRESSES: Members of the public may participate by dialing 1-202-366-3920, pass code 6934 on June 20th, and by dialing 1-202-366-3920, pass code 7124 on June 29th. Public participation is welcomed; however, the number of teleconference lines is limited and available on a first-come, first-served basis. Members of the public may also participate by coming to Room 1208, U.S. Coast Guard Headquarters, 2100 Second Street, SW., Washington, DC 20593-0001. FOR FURTHER INFORMATION CONTACT: For questions on this notice, contact Mr. Gould, Assistant to the Executive Director, telephone 202-372-1409, fax 202-372-1926, or e-mail *mgould@comdt.uscg.mil* . SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act, 5 U.S.C. App. 2 (Pub. L. 92-463, 86 Stat. 770, as amended). Tentative Agendas Tuesday, June 20, 2006 12 p.m.-12:05 p.m.: Welcome and Opening Remarks—MERPAC Chairman Andrew McGovern. 12:05 p.m.-2:30 p.m.: Open discussion and solicitation of comments to the docket of the Transportation Security Administration's

(TSA)Transportation Worker's Identification Credential

(TWIC)proposed rules and of the Coast Guard's Merchant Mariner Credential

(MMC)proposed rules. 2:30 p.m.-3 p.m.: Public comment period. 3 p.m.: Meeting adjourned. Thursday, June 29, 2006 12 p.m.-12:05 p.m.: Welcome and Opening Remarks—MERPAC Chairman Andrew McGovern. 12:05 p.m.-2:30 p.m.: Open discussion and solicitation of comments to the docket of the Transportation Security Administration's

(TSA)Transportation Worker's Identification Credential

(TWIC)proposed rules and of the Coast Guard's Merchant Mariner Credential

(MMC)proposed rules. 2:30 p.m.-2:45 p.m.: Public comment period. 2:45 p.m.-3 p.m.: MERPAC votes on and delivers official recommendations to the Coast Guard. 3 p.m.: Meeting adjourned. Procedural All meetings are open to the public. Please note that the meetings may adjourn early if all business is finished. At the Chair's discretion, members of the public may make oral presentations during the meetings. If you would like to make an oral presentation at a meeting, please notify Mr. Gould no later than June 13, 2006. Information on Services for Individuals With Disabilities For information on facilities or services for individuals with disabilities or to request special assistance at the meetings, contact Mr. Gould as soon as possible. Dated: May 30, 2006. Howard L. Hime, Acting Director of Standards, Assistant Commandant for Prevention. [FR Doc. E6-8631 Filed 6-2-06; 8:45 am] BILLING CODE 4910-15-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-4950-FA-08] Announcement of Funding Awards for Fiscal Year 2005; Community Development Work Study Program AGENCY: Office of the Assistant Secretary for Policy Development and Research, HUD. ACTION: Announcement of funding awards. SUMMARY: In accordance with Section 102(a)(4)(C) of the Department of Housing and Urban Development Reform Act of 1989, this document notifies the public of funding awards for the Fiscal Year 2005 Community Development Work Study Program (CDWSP). The purpose of this document is to announce the names and addresses of the award winners and the amount of the awards to be used to attract economically disadvantaged and minority students to careers in community and economic development, community planning and community management, and to provide a cadre of well-qualified professionals to plan, implement, and administer local community development programs. FOR FURTHER INFORMATION CONTACT: Susan Brunson, Office of University Partnerships, U.S. Department of Housing and Urban Development, Room 8106, 451 Seventh Street, SW., Washington, DC 20410, telephone

(202)708-3061, ext. 3852. To provide service for persons who are hearing- or speech-impaired, this number may be reached via TTY by dialing the Federal Information Relay Service on

(800)877-8399, or

(202)708-1455. (Telephone numbers, other than the two “800” numbers, are not toll free.) SUPPLEMENTARY INFORMATION: The CDWSP is administered by the Office of University Partnerships under the Assistant Secretary for Policy Development and Research. The Office of University Partnerships administers HUD's ongoing grant programs to institutions of higher education. These colleges and universities assist in bringing their traditional missions of teaching, research, service, and outreach to bear on the pressing local problems in their communities. The CDWSP was enacted in the Housing and Community Development Act of 1988. (Earlier versions of the program were funded by the Community Development Block Grant Technical Assistance Program from 1982 through 1987 and the Comprehensive Planning Assistance Program from 1969 through 1981.) Eligible applicants include institutions of higher education having qualifying academic degrees, and area-wide planning organizations and states that apply on behalf of such institutions. The CDWSP funds graduate programs only. Each participating institution of higher education is funded for a minimum of three and maximum of five students under the CDWSP. The CDWSP provides each participating student up to $9,000 per year for a work stipend (for internship-type work in community building) and $5,000 per year for tuition and additional support (for books and travel related to the academic program). Additionally, the CDWSP provides the participating institution of higher education with an administrative allowance of $1,000 per student per year. The Catalog of Federal Domestic Assistance number for this program is 14.512. On March 21, 2005, (70 FR 13773), HUD published a Notice of Funding Availability

(NOFA)announcing the availability of $2.8 million in FY 2005 funds and $391,144 in previously unexpended funds for the CDWSP. The Department reviewed, evaluated and scored the applications received based on the criteria in the NOFA. As a result, HUD has funded the applications announced below and, in accordance with Section 102(a)(4)(C) of the Department of Housing and Urban Development Reform Act of 1989 (103 Stat. 1987, U.S.C. 3545), the Department is publishing details concerning the recipients of funding awards as follows (More information about winners can be found at *http://www.oup.org.* ): List of Awardees for Grant Assistance Under the FY 2005 Community Development Work Study Program Funding Competition, by Name, Address, Phone Number, Grant Amount and Number of Students Funded Region I 1. University of Massachusetts, Dr. John Hird, University of Massachusetts, Terrace Research Administration Building, 70 Butterfield, Amherst, MA 01003. Grant: $90,000 to fund three students. 2. Southern New Hampshire University, Ms. Cathy LaForge, Southern New Hampshire University, 2500 North River Road, Manchester, NH 03106. Grant: $90,000 to fund three students. 3. University of Massachusetts-Lowell, Ms. Linda Concino, University of Massachusetts, 883 Broadway, 2nd Floor, Lowell, MA 01854. Grant: $90,000 to fund three students. Region II 4. Research Foundation of CUNY-Hunter College, Dr. Terry Mizrahi, Research Foundation of CUNY-Hunter College, 695 Park Avenue, New York, NY 10021. Grant: $90,000 to fund three students. 5. The Research Foundation of the State University of New York, Mr. Jeffery Schieder, The Research Foundation of the State University of New York, The UB Commons, Suite 211, 520 Lee Entrance, Amherst, NY 14228. Grant: $90,000 to fund three students. 6. Rutgers, State University of New Jersey, Mrs. Simona Turcu, Rutgers, State University of New Jersey, Rutgers Plaza, Office of Research and Sponsored Programs, New Brunswick, NJ 08901. Grant: $90,000 to fund three students. Region III 7. Virginia Polytechnic and State University, Ms. Elaine Broadstone, Virginia Polytechnic and State University, 460 Turner Street, Suite 306, Blacksburg, VA 24060. Grant: $90,000 to fund three students. 8. University of Pittsburgh, Dr. David Miller, University of Pittsburgh, Office of Research, 350 Thackeray Hall, Pittsburgh, PA 15260. Grant: $90,000 to fund three students. 9. Howard University, Mr. Wayne Patterson, Howard University, 2400 6th Street, NW., Washington, DC 20059. Grant: $90,000 to fund three students. 10. West Virginia University Research Corporation, Dr. Christopher Plein, West Virginia University Research Corporation, PO Box 6845, 866 Chestnut Ridge Road, Morgantown, WV 26506. Grant: $90,000 to fund three students. 11. Trustees of the University of Pennsylvania, Dr. Eugenie Birch, Trustees of the University of Pennsylvania, 3451 Walnut Street, P 221 Franklin Building, Philadelphia, PA 19104. Grant: $90,000 to fund three students. Region IV 12. University of Tennessee-Chattanooga, Dr. Deborah Arfken, University of Tennessee-Chattanooga, 615 McCallie Avenue, Dept. #4905, Chattanooga, TN 37403. Grant: $90,000 to fund three students. 13. North Carolina Central University, Mr. Tyrone Eaton, North Carolina Central University, 1801 Fayetteville Street, Durham, NC 27707. Grant: $90,000 to fund three students. 14. University of Alabama at Birmingham, Dr. Akhlaque Hague, University of Alabama at Birmingham, 1530 3rd Avenue, Birmingham, AL 35924. Grant: $90,000 to fund three students. 15. University of Memphis, Ms. Helen Awsumb, University of Memphis, Administration Building, Suite 315, Memphis, TN 38152. Grant: $90,000 to fund three students. 16. Florida State University, Dr. Charles Connerly, Florida State University, 97 South Woodward Avenue, Tallahassee, FL 32306. Grant: $90,000 to fund three students. 17. University of Florida, Dr. Joseli Macedo, University of Florida, PO Box 115706, Gainesville, FL 32611. Grant: $90,000 to fund three students. Region V 18. Minnesota State University-Mankota, Dr. Anthony Filipovitch, Minnesota State University-Mankota, 106 Morris Hall, Mankota, MN 56001. Grant: $90,000 to fund three students. 19. Ohio State University Research Foundation, Dr. Hazel Marrow-Jones, Ohio State University Research Foundation, 1960 Kenny Road, Columbus, OH 43210. Grant: $90,000 to fund three students. 20. Indiana University South Bend, Ms. Cindy Curvin, Indiana University South Bend, PO Box 1847, Bloomington, IN 47402. Grant: $90,000 to fund three students. 21. Michigan State University, Dr. Herb Norman, Michigan State University, 301 Administration, East Lansing, MI 48824. Grant: $90,000 to fund three students. 22. The Regents of the University of Michigan, Ms. Gayle Jackson, The Regents of the University of Michigan, 3003 S. State Street, Wolverine Tower Building, Room 1044, Ann Arbor, MI 48109. Grant: $90,000 to fund three students. 23. University of Illinois-Chicago, Dr. Curtis Winkle, University of Illinois-Chicago, MB 502, M/C 551, 809 S. Marshfield Avenue, Chicago, IL 60612. Grant: $90,000 to fund three students. 24. Cleveland State University, Dr. Wendy Kellogg, Cleveland State University, 2121 Euclid Avenue, Cleveland, OH 44115. Grant: $90,000 to fund three students. 25. University of Minnesota, Ms. Darville, University of Minnesota, 200 Oak Street, SE, 450 McNamara Alumni Center, Minneapolis, MN 55455. Grant: $90,000 to fund three students. 26. University of Wisconsin-Milwaukee, Mr. Stephen Percy, University of Wisconsin-Milwaukee, PO Box 340, Milwaukee, WI 53201. Grant: $90,000 to fund three students. Region VI 27. North Central Texas Council of Government, Ms. Lucille Johnson, North Central Texas Council of Government, PO Box 5888, Arlington, TX 76005. Grant: $270,000 to fund three students at three institutions. Region VII 28. University of Nebraska at Omaha, Dr. Russell Smith, University of Nebraska at Omaha, 6001 Dodge Street, Omaha, NE 68182. Grant: $90,000 to fund three students. 29. University of Kansas Center for Research, Mr. John Nalbandian, University of Kansas Center for Research, 2385 Irving Hill, Lawrence, KS 66045. Grant: $90,000 to fund three students. 30. Kansas State University, Mr. Larry L. Lawhon, Kansas State University, 2 Fairchild Hall, Manhattan, KS 66506. Grant: $90,000 to fund three students. 31. Iowa State University, Mr. Thane Peterson, Iowa State University, 1138 Pearson, Ames, IA 50011. Grant: $90,000 to fund three students. Region IX 32. University of Southern California, Mr. Leonard Mitchell, University of Southern California, University Park Campus, Los Angeles, CA 90089. Grant: $90,000 to fund three students. 33. California Polytechnic State University, Ms. Patti Wilhelm, California Polytechnic State University, 1 Grand Avenue, San Luis Obispo, CA 93407. Grant: $90,000 to fund three students. 34. The Regents of the University of California, Ms. Susan Hedley, The Regents of the University of California, 336 Sproull Hall, MC 5940, Berkeley, CA 94720. Grant: $90,000 to fund three students. Region X 35. University of Oregon, Ms. Megan Smith, University of Oregon, 5219 University of Oregon, Eugene, OR 97403. Grant: $90,000 to fund three students. 36. Eastern Washington University, Dr. Fred Hurand, Eastern Washington University, 210 Showalter Hall, Cheney, WA 99004. Grant: $90,000 to fund three students. Dated: May 26, 2006. Darlene F. Williams, Assistant Secretary. [FR Doc. E6-8639 Filed 6-2-06; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-4513-N-24] Credit Watch Termination Initiative AGENCY: Office of the Assistant Secretary for Housing-Federal Housing Commissioner, HUD. ACTION: Notice. SUMMARY: This notice advises of the cause and effect of termination of Origination Approval Agreements taken by HUD's Federal Housing Administration

(FHA)against HUD-approved mortgagees through the FHA Credit Watch Termination Initiative. This notice includes a list of mortgagees which have had their Origination Approval Agreements terminated. FOR FURTHER INFORMATION CONTACT: The Quality Assurance Division, Office of Housing, Department of Housing and Urban Development, 451 Seventh Street, SW., Room B133-P3214, Washington, DC 20410-8000; telephone

(202)708-2830 (this is not a toll free number). Persons with hearing or speech impairments may access that number through TTY by calling the Federal Information Relay Service at

(800)877-8339. SUPPLEMENTARY INFORMATION: HUD has the authority to address deficiencies in the performance of lenders' loans as provided in HUD's mortgagee approval regulations at 24 CFR 202.3. On May 17, 1999 (64 FR 26769), HUD published a notice on its procedures for terminating Origination Approval Agreements with FHA lenders and placement of FHA lenders on Credit Watch status (an evaluation period). In the May 17, 1999 notice, HUD advised that it would publish in the **Federal Register** a list of mortgagees, which have had their Origination Approval Agreements terminated. *Termination of Origination Approval Agreement:* Approval of a mortgagee by HUD/FHA to participate in FHA mortgage insurance programs includes an Origination Approval Agreement (Agreement) between HUD and the mortgagee. Under the Agreement, the mortgagee is authorized to originate single family mortgage loans and submit them to FHA for insurance endorsement. The Agreement may be terminated on the basis of poor performance of FHA-insured mortgage loans originated by the mortgagee. The termination of a mortgagee's Agreement is separate and apart from any action taken by HUD's Mortgagee Review Board under HUD's regulations at 24 CFR part 25. *Cause:* HUD's regulations permit HUD to terminate the Agreement with any mortgagee having a default and claim rate for loans endorsed within the preceding 24 months that exceeds 200 percent of the default and claim rate within the geographic area served by a HUD field office, and also exceeds the national default and claim rate. For the 26th review period, HUD is terminating the Agreement of mortgagees whose default and claim rate exceeds both the national rate and 200 percent of the field office rate. *Effect:* Termination of the Agreement precludes that branch(s) of the mortgagee from originating FHA-insured single family mortgages within the area of the HUD field office(s) listed in this notice. Mortgagees authorized to purchase, hold, or service FHA insured mortgages may continue to do so. Loans that closed or were approved before the termination became effective may be submitted for insurance endorsement. Approved loans are

(1)those already underwritten and approved by a Direct Endorsement

(DE)underwriter employed by an unconditionally approved DE lender and

(2)cases covered by a firm commitment issued by HUD. Cases at earlier stages of processing cannot be submitted for insurance by the terminated branch; however, they may be transferred for completion of processing and underwriting to another mortgagee or branch authorized to originate FHA insured mortgages in that area. Mortgagees are obligated to continue to pay existing insurance premiums and meet all other obligations associated with insured mortgages. A terminated mortgagee may apply for a new Origination Approval Agreement if the mortgagee continues to be an approved mortgagee meeting the requirements of 24 CFR 202.5, 202.6, 202.7, 202.8 or 202.10 and 202.12, if there has been no Origination Approval Agreement for at least six months, and if the Secretary determines that the underlying causes for termination have been remedied. To enable the Secretary to ascertain whether the underlying causes for termination have been remedied, a mortgagee applying for a new Origination Approval Agreement must obtain an independent review of the terminated office's operations as well as its mortgage production, specifically including the FHA-insured mortgages cited in its termination notice. This independent analysis shall identify the underlying cause for the mortgagee's high default and claim rate. The review must be conducted and issued by an independent Certified Public Accountant

(CPA)qualified to perform audits under Government Auditing Standards as provided by the General Accounting Office. The mortgagee must also submit a written corrective action plan to address each of the issues identified in the CPA's report, along with evidence that the plan has been implemented. The application for a new Agreement should be in the form of a letter, accompanied by the CPA's report and corrective action plan. The request should be sent to the Director, Office of Lender Activities and Program Compliance, 451 Seventh Street, SW., Room B133-P3214, Washington, DC 20410-8000 or by courier to 490 L'Enfant Plaza, East, SW., Suite 3214, Washington, DC 20024-8000. *Action:* The following mortgagees have had their Agreements terminated by HUD: Mortgagee name Mortgagee branch address HUD office jurisdictions Termination effective date Homeownership centers Allied Home MTG Capital Corp 141 J Technology Dr., Garner, NC 27529 Greensboro 3/30/06 Atlanta. Creative Mortgage Inc. 5200 DTE Pkwy, Ste. 400, Englewood, CO 80111 Denver 3/30/06 Denver. Everett Financial Inc. 17290 Preston RD Ste. 300, Dallas, TX 75252 Dallas 3/30/06 Denver. International Lending Solutions Inc 6041 S. Syracuse Way Ste. 200, Greenwood Village, CO 80111 Denver 2/19/06 Denver. WR Starkey Mortgage LLP 700 Highlander Blvd., Arlington, TX 70615 Fort Worth 3/30/06 Denver. Dated: May 25, 2006. Brian D. Montgomery, Assistant Secretary for Housing-Federal Housing Commissioner. [FR Doc. E6-8638 Filed 6-2-06; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-4639-N-10] Notice of HUD-Held Multifamily and Healthcare Loan Sale (MHLS 2006-1) AGENCY: Office of the Assistant Secretary for Housing-Federal Housing Commissioner, HUD. ACTION: Notice of sale of mortgage loans. SUMMARY: This notice announces HUD's intention to sell certain unsubsidized multifamily and healthcare mortgage loans, without Federal Housing Administration

(FHA)insurance, in a competitive, sealed bid sale (MHLS 2006-1). This notice also describes generally the bidding process for the sale and certain persons who are ineligible to bid. DATES: The Bidder's Information Package

(BIP)will be made available to qualified bidders on May 17, 2006. Bids for the loans must be submitted on the bid date, which is currently scheduled for June 21, 2006. HUD anticipates that awards will be made on or before June 22, 2006. Closings are expected to take place on June 28, 2006. ADDRESSES: To become a qualified bidder and receive the BIP, prospective bidders must complete, execute, and submit a Confidentiality Agreement and a Qualification Statement acceptable to HUD. Both documents will be available on the HUD Web site at *http://www.hud.gov/offices/hsg/comp/asset/mfam/mhls.cfm.* The executed documents must be mailed and faxed to SSD Inc., HUD's Transaction Specialist for the sale, at 1400 K Street, NW., Suite 950, Attention: MHLS 2006-1 Sale Coordinator, Fax:

(202)464-3047. FOR FURTHER INFORMATION CONTACT: John Lucey, Acting Deputy Director, Asset Sales Office, Department of Housing and Urban Development, 451 Seventh Street, SW., Room 3136, Washington, DC 20410-8000; telephone

(202)708-2625, extension 3927 or Gregory Bolton, Senior Attorney, Office of Insured Housing, Multifamily Division, Room 9230; telephone

(202)708-0614, extension 5245. Hearing- or speech-impaired individuals may call

(202)708-4594 (TTY). These are not toll-free numbers. SUPPLEMENTARY INFORMATION: HUD announces its intention to sell in MHLS 2006-1 certain unsubsidized mortgage loans (Mortgage Loans) secured by multifamily and healthcare properties located throughout the United States. The Mortgage Loans are comprised primarily of non-performing mortgage loans. A final listing of the Mortgage Loans will be included in the BIP. The Mortgage Loans will be sold without FHA insurance and with servicing released. HUD will offer qualified bidders an opportunity to bid competitively on the Mortgage Loans. The Mortgage Loans will be stratified for bidding purposes into several mortgage loan pools. Each pool will contain Mortgage Loans that generally have similar performance, property type, geographic location, lien position and other characteristics. Qualified bidders may submit bids on one or more pools of Mortgage Loans or may bid on individual loans. A mortgagor who is a qualified bidder may submit an individual bid on its own Mortgage Loan. Interested Mortgagors should review the Qualification Statement to determine whether they may also be eligible to qualify to submit bids on one or more pools of Mortgage Loans or on individual loans in MHLS 2006-1. The Bidding Process The BIP will describe in detail the procedure for bidding in MHLS 2006-1. The BIP will also include a standardized nonnegotiable loan sale agreement (Loan Sale Agreement). As part of its bid, each bidder must submit a deposit equal to the greater of $100,000 or 10% of the bid price. HUD will evaluate the bids submitted and determine the successful bids in its sole and absolute discretion. If a bidder is successful, the bidder's deposit will be non-refundable and will be applied toward the purchase price. Deposits will be returned to unsuccessful bidders. Closings are scheduled to occur on June 28, 2006. These are the essential terms of sale. The Loan Sale Agreement, which will be included in the BIP, will contain additional terms and details. To ensure a competitive bidding process, the terms of the bidding process and the Loan Sale Agreement are not subject to negotiation. Due Diligence Review The BIP will describe the due diligence process for reviewing loan files in MHLS 2006-1. Qualified bidders will be able to access loan information remotely via a high-speed Internet connection. Further information on performing due diligence review of the Mortgage Loans will be provided in the BIP. Mortgage Loan Sale Policy HUD reserves the right to add Mortgage Loans to or delete Mortgage Loans from MHLS 2006-1 at any time prior to the Award Date. HUD also reserves the right to reject any and all bids, in whole or in part, without prejudice to HUD's right to include any Mortgage Loans in a later sale. Mortgage Loans will not be withdrawn after the Award Date except as is specifically provided in the Loan Sale Agreement. This is a sale of unsubsidized mortgage loans. Pursuant to the Multifamily Mortgage Sale Regulations, 24 CFR 290.30 *et seq.* , the Mortgage Loans will be sold without FHA insurance. Consistent with HUD's policy as set forth in 24 CFR 290.35, HUD is unaware of any Mortgage Loan that is delinquent and secures a project

(1)for which foreclosure appears unavoidable, and

(2)in which very-low income tenants reside who are not receiving housing assistance and who would be likely to pay rent in excess of 30 percent of their adjusted monthly income if HUD sold the Mortgage Loan. If HUD determines that any Mortgage Loans meet these criteria, they will be removed from the sale. Mortgage Loan Sale Procedure HUD selected a competitive sale as the method to sell the Mortgage Loans primarily to satisfy the Mortgage Sale Regulations. This method of sale optimizes HUD's return on the sale of these Mortgage Loans, affords the greatest opportunity for all qualified bidders to bid on the Mortgage Loans, and provides the quickest and most efficient vehicle for HUD to dispose of the Mortgage Loans. Bidder Eligibility In order to bid in the sale, a prospective bidder must complete, execute and submit both a Confidentiality Agreement and a Qualification Statement acceptable to HUD. The following individuals and entities are ineligible to bid on any of the Mortgage Loans included in MHLS 2006-1:

(1)Any employee of HUD, a member of such employee's household, or an entity owned or controlled by any such employee or member of such an employee's household;

(2)Any individual or entity that is debarred, suspended, or excluded from doing business with HUD pursuant to Title 24 of the Code of Federal Regulations, part 24;

(3)Any contractor, subcontractor and/or consultant or advisor (including any agent, employee, partner, director, principal or affiliate of any of the foregoing) who performed services for or on behalf of HUD in connection with MHLS 2006-1;

(4)Any individual who was a principal, partner, director, agent or employee of any entity or individual described in subparagraph 3 above, at any time during which the entity or individual performed services for or on behalf of HUD in connection with MHLS 2006-1;

(5)Any individual or entity that uses the services, directly or indirectly, of any person or entity ineligible under subparagraphs 1 through 4 above to assist in preparing any of its bids on the Mortgage Loans;

(6)Any individual or entity which employs or uses the services of an employee of HUD (other than in such employee's official capacity) who is involved in MHLS 2006-1;

(7)Any mortgagor (or affiliate of a mortgagor) that failed to submit to HUD on or before March 31, 2006, audited financial statements for 1999 through 2005 for a project securing a Mortgage Loan; and

(8)Any individual or entity and any Related Party (as such term is defined in the Qualification Statement) of such individual or entity that is a mortgagor in any of HUD's multifamily housing programs and that is in default under such mortgage loan or is in violation of any regulatory or business agreements with HUD, unless such default or violation is cured on or before June 14, 2006. In addition, any entity or individual that serviced or held any Mortgage Loan at any time during the 2-year period prior to May 31, 2006, is ineligible to bid on such Mortgage Loan or on the pool containing such Mortgage Loan, but may bid on loan pools that do not contain Mortgage Loans that they have serviced or held at any time during the 2-year period prior to May 31, 2006. Also ineligible to bid on any Mortgage Loan are:

(a)Any affiliate or principal of any entity or individual described in the preceding sentence;

(b)any employee or subcontractor of such entity or individual during that 2-year period; or

(c)any entity or individual that employs or uses the services of any other entity or individual described in this paragraph in preparing its bid on such Mortgage Loan. Prospective bidders should carefully review the Qualification Statement to determine whether they are eligible to submit bids on the Mortgage Loans in MHLS 2006-1. Freedom of Information Act Requests HUD reserves the right, in its sole and absolute discretion, to disclose information regarding MHLS 2006-1, including, but not limited to, the identity of any successful bidder and its bid price or bid percentage for any pool of loans or individual loan, upon the closing of the sale of all the Mortgage Loans. Even if HUD elects not to publicly disclose any information relating to MHLS 2006-1, HUD will have the right to disclose any information that HUD is obligated to disclose pursuant to the Freedom of Information Act and all regulations promulgated thereunder. Scope of Notice This notice applies to MHLS 2006-1 and does not establish HUD's policy for the sale of other mortgage loans. Dated: May 25, 2006. Brian D. Montgomery, Assistant Secretary for Housing-Federal Housing Commissioner. [FR Doc. E6-8640 Filed 6-2-06; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [CA 660-06-5101-ER] Proposed Wind Energy Project AGENCY: Bureau of Land Management, Interior. ACTION: Notice of intent to prepare a joint Environmental Impact Statement

(EIS)and Environmental Impact Report (EIR). SUMMARY: In compliance with the National Environmental Policy Act

(NEPA)of 1969, 40 CFR 1508.22, and the California Environmental Quality Act (CEQA), notice is herby given that the Bureau of Land Management

(BLM)and the City of Palm Springs intend to prepare a joint Environmental Impact Statement

(EIS)and Environmental Impact Report

(EIR)for a proposed wind energy facility on public and private land in the Coachella Valley. The EIS/EIR will describe and analyze alternatives for a proposed wind energy generating facility on approximately 600 acres in the Whitewater floodplain in the Coachella Valley, Riverside County, California. DATES: This notice initiates the public scoping process. Comments on issues may be submitted in writing to the address listed below. Additionally, a public meeting will be held to encourage public input. The public meeting will be announced through the local news media, newspapers, and the BLM Web site ( *http://www.ca.blm.gov/palmsprings* ) at least 15 days prior to the event. Additional opportunities for public participation will be provided upon publication of the draft EIS/EIR. ADDRESSES: Comments should be sent to Greg Hill, Wind Energy Project, Bureau of Land Management, 690 W. Garnet Ave., P.O. Box 581260, North Palm Springs, CA 92258 or by fax at

(760)251-4899, or by e-mail at *gchill@ca.blm.gov.* Documents pertinent to this proposal, including comments with the names and addresses of respondents, will be available for public review at the BLM Palm Springs-South Coast Field Office located at 690 W. Garnet Avenue, North Palm Springs, California, during regular business hours of 7:45 a.m. to 4:30 p.m., Monday through Friday, except holidays, and may be published as part of the EIS/EIR. Individual respondents may request confidentiality. If you wish to withhold your name or street address from public review or from disclosure under the Freedom of Information Act, you must state this prominently at the beginning of your written comment. Such requests will be honored to the extent allowed by law. BLM will not consider anonymous comments. All submissions from organizations and businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, will be available for public inspection in their entirety. FOR FURTHER INFORMATION CONTACT: For further information and/or to have your name added to our mailing list, contact Greg Hill, Wind Energy Project, Bureau of Land Management, Palm Springs-South Coast Field Office,

(760)251-4840, or by e-mail at *gchill@ca.blm.gov.* SUPPLEMENTARY INFORMATION: Mountain View Power Partners IV, LLC has applied for a right of way on public lands and a conditional use permit on private lands to construct a wind energy generating facility in the Coachella Valley, in Riverside County. The project site is west of Indian Avenue and is within the corporate boundary of the City of Palm Springs and within the planning area for the draft Coachella Valley Multiple Species Habitat Conservation Plan. Operations are expected to last approximately 30 years. The proposed project would install a total of approximately 42 to 50 wind turbines on public and private lands, with a total generating capacity of approximately 49 megawatts. Related structures would include access roads, a 34.5kV powerline and an electrical substation. If approved, the wind energy generating facility on public lands would be authorized in accordance with Title V of the Federal Land Policy and Management Act of 1976 (U.S.C.) and the Federal regulations at 43 CFR 2800. The proposed project would take approximately 7 months to construct. Dated: January 10, 2006. Gail Acheson, Field Manager, Palm Springs-South Coast Field Office. [FR Doc. E6-8681 Filed 6-2-06; 8:45 am] BILLING CODE 4310-40-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [NM-952-06-1420-BJ] Notice of Filing of Plats of Survey; New Mexico AGENCY: Bureau of Land Management, Interior. ACTION: Notice. SUMMARY: The plats of survey described below are scheduled to be officially filed in the New Mexico State Office, Bureau of Land Management, Santa Fe, New Mexico

(30)thirty calendar days from the date of this publication. SUPPLEMENTARY INFORMATION: New Mexico Principal Meridian, New Mexico: The plat representing the dependent resurvey and survey and subdivision of sections in township 24 North, Ranges 9 East, accepted March 30, 2006, for Group 1032 New Mexico. The supplemental plat, representing the subdivision of sections for Township 20 North, Range 9 & 10 East, accepted March 30, 2006, for New Mexico. The plat representing the dependent resurvey and subdivision of sections for Township 22 South, Range 2 East, accepted March 29, 2006 for Group 937 New Mexico. The plat representing the dependent resurvey and survey for Township 16 North, Range 17 East, accepted January 12, 2006 for Group 1030 New Mexico. The plat representing the dependent resurvey and subdivision of sections for Township 15 North, Range 1 East, accepted December 29, 2005 for Group 1031 New Mexico. The plat representing the dependent resurvey and subdivision of sections for Township 26 North, Range 6 East, accepted December 12, 2005 for Group 943 New Mexico. The plat, in two sheets, representing the dependent resurvey and survey for Township 13 North, Range 12 West, accepted May 9, 2006, for Group 1013 New Mexico. Indian Meridian, Oklahoma: The plat representing the dependent resurvey and survey for Township 8 North, Range 7 East, accepted February 6, 2006, for Group 108 Oklahoma. The plat representing the dependent resurvey and survey for Township 9 south, Range 1 East, accepted March 10, 2006 for Group 132 Oklahoma. The plat representing the dependent resurvey and survey for Township 8 North, Range 14 East, accepted April 5, 2006 for Group 119 Oklahoma. The plat representing the dependent resurvey and survey for Township 22 North, Range 4 East, accepted April 12, 2006 for Group 137 Oklahoma. If a protest against a survey, as shown on any of the above plats is received prior to the date of official filing, the filing will be stayed pending consideration of the protest. A plat will not be officially filed until the day after all protests have been dismissed. A person or party who wishes to protest against any of these surveys must file a written protest with the New Mexico State Director, Bureau of Land Management, stating that they wish to protest. A statement of reasons for a protest may be filed with the notice of protest to the State Director, or the statement of reasons must be filed with the State Director within thirty days after the protest is filed. FOR FURTHER INFORMATION CONTACT: These plats will be available for inspection in the New Mexico State Office, Bureau of Land Management, and P.O. Box 27115, Santa Fe, New Mexico, 87502-0115. Copies may be obtained from this office upon payment of $1.10 per sheet. Dated: May 23, 2006. Robert A. Casias, Chief Cadastral Surveyor, New Mexico. [FR Doc. 06-5080 Filed 6-2-06; 8:45 am]

Connectionstraces to 8

Traces to 8 documents

U.S. Code

CFR

statutes-at-large